Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| UroGen Pharma Ltd. | 153,195 | reported | 31 Jan 2026 | tx 65+2,201,459−514,200 |
| Allogene Therapeutics, Inc. | 95,400 | reported | 18 Jun 2025 | tx 5+537,057 |
| Sage Therapeutics, Inc. | 0 | reported | 31 Jul 2025 | tx 3+21,500−24,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jan 2026 | GRANT_AWARD | UroGen Pharma Ltd. | 153,195 | 0.00 USD | deriv |
| 31 Jul 2025 | TENDER | Sage Therapeutics, Inc. | 3,000 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 21,500 | — | deriv |
| 28 Jul 2025 | GRANT_AWARD | UroGen Pharma Ltd. | 87,615 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 95,400 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 21,500 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | UroGen Pharma Ltd. | 96,377 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Allogene Therapeutics, Inc. | 191,082 | 0.00 USD | deriv |
| 31 Jan 2024 | GRANT_AWARD | UroGen Pharma Ltd. | 87,615 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Allogene Therapeutics, Inc. | 116,120 | 0.00 USD | deriv |
| 31 Jan 2023 | EXERCISE | UroGen Pharma Ltd. | 13,333 | — | |
| 31 Jan 2023 | EXERCISE | UroGen Pharma Ltd. | 5,000 | — | |
| 31 Jan 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 100,000 | 0.00 USD | deriv |
| 31 Jan 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 125,000 | 0.00 USD | deriv |
| 31 Jan 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 75,000 | 0.00 USD | deriv |
| 31 Jan 2023 | EXERCISE | UroGen Pharma Ltd. | 13,333 | 0.00 USD | deriv |
| 31 Jan 2023 | EXERCISE | UroGen Pharma Ltd. | 5,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Allogene Therapeutics, Inc. | 71,070 | 0.00 USD | deriv |
| 31 Jan 2022 | SALE | UroGen Pharma Ltd. | 5,960 | 7.58 USD | |
| 31 Jan 2022 | EXERCISE | UroGen Pharma Ltd. | 5,000 | — | |
| 31 Jan 2022 | SALE | UroGen Pharma Ltd. | 2,235 | 7.58 USD | |
| 31 Jan 2022 | EXERCISE | UroGen Pharma Ltd. | 13,333 | — | |
| 31 Jan 2022 | EXERCISE | UroGen Pharma Ltd. | 13,333 | 0.00 USD | deriv |
| 31 Jan 2022 | EXERCISE | UroGen Pharma Ltd. | 5,000 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | UroGen Pharma Ltd. | 150,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 14 Dec 2020.